- Home
- Miscellaneous Information on Celiac Disease
- Celiac Disease Research Projects, Fundraising, Epidemiology, Etc.
- Greek Rate of Celiac Disease Among Lowest in Europe
Greek Rate of Celiac Disease Among Lowest in Europe
- By Jefferson Adams
- Published 01/29/2008
- Celiac Disease Research Projects, Fundraising, Epidemiology, Etc.
-
Rating:
Jefferson Adams
Jefferson Adams is a freelance writer living in San Francisco. His poems, essays and photographs have appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate among others.
View all articles by Jefferson AdamsGreeks Rates of Celiac Disease Among Lowest in Europe
Celiac.com 01/29/2008 - If the results of a recent study are any indication, the Greeks might be among those least affected by celiac disease.
The study on the prevalence of celiac disease in Greece shows that the people of Thessaly have a prevalence of celiac disease that is among the lowest of all the European populations.
Recent discoveries point to a greater prevalence of celiac disease than previously expected in a number of European populations, and the availability of new, accurate serological tests has made screening in the general population possible. These facts, coupled with the reality that no data exist regarding the prevalence of celiac disease in Greece, recently sparked a team of researchers to use a novel diagnostic algorithm to examine the general population of Thessaly, in central Greece, in an effort to determine rates of prevalence for celiac disease.
Led by doctors Roka V, Potamianos SP, Kapsoritakis AN, Yiannaki EE, Koukoulis GN, Stefanidis I, Koukoulis GK, Germenis AE, the researcher team selected 2230 participants (1226 women, 1004 men, median age 46 years, range 18-80 years) by a random sampling from the adult general population of Thessaly.
The researchers took blood samples and checked them for total immunoglobulin A (IgA)-serum levels, to eliminate IgA deficiency. The research team then examined samples that showed total IgA within the normal range for IgA antibodies compared to native human-tissue transglutaminase (anti-tTG); the researchers then tested samples that were anti-tTG positive for IgA antiendomysial antibodies (EmA).
The researchers then examined samples from participants with selective IgA deficiency for IgG antigliadin antibodies. They referred for biopsy and human leucocyte antigen (HLA) typing those participants that showed EmA-positive or antigliadin antibody-positive.
No participant with selective IgA deficiency was detected. Four individuals tested positive for EmA, all of whom were biopsy-proven coeliacs. Therefore, the prevalence of celiac disease within this general population sample is 1: 558 or 1.8 per 1000 (SE 0.13).
The two men, two women that did show abnormal histology were between the ages of 18 and 35. Two of them were considered to be asymptomatic and two presented with a sub-clinical course. All four showed the heterodimer HLA-DQ2.
The evidence indicates that the people of the central Greek area of Thessaly have a prevalence of celiac disease that is among the lowest of all the European populations.
Eur. J. Gastroenterol Hepatol. 2007 Nov;19(11):982-7.
The study on the prevalence of celiac disease in Greece shows that the people of Thessaly have a prevalence of celiac disease that is among the lowest of all the European populations.
Recent discoveries point to a greater prevalence of celiac disease than previously expected in a number of European populations, and the availability of new, accurate serological tests has made screening in the general population possible. These facts, coupled with the reality that no data exist regarding the prevalence of celiac disease in Greece, recently sparked a team of researchers to use a novel diagnostic algorithm to examine the general population of Thessaly, in central Greece, in an effort to determine rates of prevalence for celiac disease.
Led by doctors Roka V, Potamianos SP, Kapsoritakis AN, Yiannaki EE, Koukoulis GN, Stefanidis I, Koukoulis GK, Germenis AE, the researcher team selected 2230 participants (1226 women, 1004 men, median age 46 years, range 18-80 years) by a random sampling from the adult general population of Thessaly.
The researchers took blood samples and checked them for total immunoglobulin A (IgA)-serum levels, to eliminate IgA deficiency. The research team then examined samples that showed total IgA within the normal range for IgA antibodies compared to native human-tissue transglutaminase (anti-tTG); the researchers then tested samples that were anti-tTG positive for IgA antiendomysial antibodies (EmA).
The researchers then examined samples from participants with selective IgA deficiency for IgG antigliadin antibodies. They referred for biopsy and human leucocyte antigen (HLA) typing those participants that showed EmA-positive or antigliadin antibody-positive.
No participant with selective IgA deficiency was detected. Four individuals tested positive for EmA, all of whom were biopsy-proven coeliacs. Therefore, the prevalence of celiac disease within this general population sample is 1: 558 or 1.8 per 1000 (SE 0.13).
The two men, two women that did show abnormal histology were between the ages of 18 and 35. Two of them were considered to be asymptomatic and two presented with a sub-clinical course. All four showed the heterodimer HLA-DQ2.
The evidence indicates that the people of the central Greek area of Thessaly have a prevalence of celiac disease that is among the lowest of all the European populations.
Eur. J. Gastroenterol Hepatol. 2007 Nov;19(11):982-7.
Subscribe to free Celiac.com email alerts (1-3 email per month with the latest celiac disease research and information, gluten-free recipes, etc.).
Spread The Word
4 Responses to "Greek Rate of Celiac Disease Among Lowest in Europe"
|
said this on 03 Feb 2008 11:08:14 PM PST
Inter
|
Author)|
said this on 18 Feb 2008 8:22:27 AM PST
I wil
|
|
said this on 04 Mar 2008 1:36:41 PM PST
I am
|
|
said this on 16 Apr 2008 12:55:34 AM PST
After
|